<DOC>
	<DOCNO>NCT01266655</DOCNO>
	<brief_summary>There first evidence preclinical clinical study efficacy selective GABA-B receptor agonist baclofen treatment alcohol dependence . The aim trial evaluate efficacy safety individually titrate high-dose baclofen relapse prevention alcohol-dependent patient .</brief_summary>
	<brief_title>Baclofen Treatment Alcohol Dependence</brief_title>
	<detailed_description />
	<mesh_term>Alcoholism</mesh_term>
	<criteria>Diagnosis alcohol dependence accord ICD10 ( International Classification Mental Behavioural Disorders , 10th revision ) DSMIV ( Diagnostic Statistical Manual Mental Disorders , 4th revision ) criteria An alcohol intake least two heavy drinking day per week average ( men ≥ 5 drink per day ; woman ≥ 4 drink per day ) average overall consumption 21 drink per week men 14 drink per week woman 4 week detoxification ( one standard drink equal 12 g absolute alcohol ) Last alcohol consumption within 721 day randomisation Sufficient German language capability Pregnancy and/or currently breastfeed Clinical significant medical condition observe abnormality Psychiatric illness undergo treatment psychoactive drug Epilepsy epileptiform convulsion Addiction drug nicotine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>